2023-2029 Global PD-1 and PD-L1 Drug Industry Research & Trends Analysis Report
According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, PD-1 Monoclonal Antibody segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Liver Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of PD-1 and PD-L1 Drug include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.
This report aims to provide a comprehensive study of the global market for PD-1 and PD-L1 Drug. Report Highlights:
(1) Global PD-1 and PD-L1 Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global PD-1 and PD-L1 Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global PD-1 and PD-L1 Drug segment by type and by application and regional segment by type and by application.
(6) Global major production regions of PD-1 and PD-L1 Drug, capacity, production and trends.
(7) PD-1 and PD-L1 Drug industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
PD-1 Monoclonal Antibody
PD-L1 Monoclonal Antibody
Market segment by application, can be divided into
Liver Cancer
Esophageal Cancer
Nasal Cancer
Stomach Cancer
Other
Market segment by players, this report covers
Bristol Myers Squibb
Merck & Co., Inc.
F. Hoffmann -La Roche Ltd
AstraZeneca
Sanofi
Pfizer Inc
Lilly
Novartis AG
GSK
Junshi Biosciences
Akeso, Inc
BeiGene
Innovent
Jiangsu Hengrui Medicine Co.,Ltd
Cstone
Henlius
Simcere Pharmaceutical Group Limited
1 Market Overview
1.1 PD-1 and PD-L1 Drug Definition
1.2 Global PD-1 and PD-L1 Drug Market Size and Forecast
1.2.1 By Revenue, Global PD-1 and PD-L1 Drug Market Size, 2018-2029
1.2.2 By Sales Volume, Global PD-1 and PD-L1 Drug Market Size, 2018-2029
1.2.3 Global PD-1 and PD-L1 Drug Price Trend, 2018-2029
1.3 China PD-1 and PD-L1 Drug Market Size and Forecast
1.3.1 By Revenue, China PD-1 and PD-L1 Drug Market Size, 2018-2029
1.3.2 By Sales Volume, China PD-1 and PD-L1 Drug Market Size, 2018-2029
1.3.3 China PD-1 and PD-L1 Drug Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029
1.4.3 PD-1 and PD-L1 Drug Market Size: China VS Global, 2018-2029
1.5 PD-1 and PD-L1 Drug Market Dynamics
1.5.1 PD-1 and PD-L1 Drug Market Drivers
1.5.2 PD-1 and PD-L1 Drug Market Restraints
1.5.3 PD-1 and PD-L1 Drug Industry Trends
1.5.4 PD-1 and PD-L1 Drug Industry Policy
2 Global Competitive Landscape by Company
2.1 Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023
2.2 Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023
2.3 Global PD-1 and PD-L1 Drug Price by Company, 2018-2023
2.4 Global PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global PD-1 and PD-L1 Drug Concentration Ratio
2.6 Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
2.7 Global PD-1 and PD-L1 Drug Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023
3.2 China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023
3.3 China PD-1 and PD-L1 Drug PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China PD-1 and PD-L1 Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, PD-1 and PD-L1 Drug Domestic VS Export
3.6 China Market, PD-1 and PD-L1 Drug Import & Export
3.6.1 China Market, PD-1 and PD-L1 Drug Import & Export, 2018-2029
3.6.2 China PD-1 and PD-L1 Drug Import & Export Trends
3.6.3 Main Sources of China PD-1 and PD-L1 Drug Import
3.6.4 Export Destination of China PD-1 and PD-L1 Drug
4 PD-1 and PD-L1 Drug Production by Region
4.1 Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of PD-1 and PD-L1 Drug Manufacturers
4.3 Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans
4.4 Global PD-1 and PD-L1 Drug Capacity by Region
4.5 Global PD-1 and PD-L1 Drug Production by Region
4.5.1 Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global PD-1 and PD-L1 Drug Production by Region, 2018-2023
4.5.3 Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 PD-1 and PD-L1 Drug Industry Chain
5.2 PD-1 and PD-L1 Drug Upstream Analysis
5.2.1 PD-1 and PD-L1 Drug Core Raw Materials
5.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 PD-1 and PD-L1 Drug Production Mode
5.6 PD-1 and PD-L1 Drug Procurement Model
5.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels
5.7.1 PD-1 and PD-L1 Drug Sales Model
5.7.2 PD-1 and PD-L1 Drug Typical Distributors
6 Sights by Type
6.1 PD-1 and PD-L1 Drug Classification
6.1.1 PD-1 Monoclonal Antibody
6.1.2 PD-L1 Monoclonal Antibody
6.2 By Type, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
6.4 By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
6.5 By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029
7 Sights by Application
7.1 PD-1 and PD-L1 Drug Segment by Application
7.1.1 Liver Cancer
7.1.2 Esophageal Cancer
7.1.3 Nasal Cancer
7.1.4 Stomach Cancer
7.1.5 Other
7.2 By Application, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
7.4 By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
7.5 By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
8.3 By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
8.4 North America
8.4.1 North America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America PD-1 and PD-L1 Drug Market Size Market Share
8.5 Europe
8.5.1 Europe PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe PD-1 and PD-L1 Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Market Size Market Share
8.7 South America
8.7.1 South America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America PD-1 and PD-L1 Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global PD-1 and PD-L1 Drug Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029
9.3 By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. PD-1 and PD-L1 Drug Market Size, 2018-2029
9.4.2 By Company, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.4.3 By Type, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe PD-1 and PD-L1 Drug Market Size, 2018-2029
9.5.2 By Company, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.5.3 By Type, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China PD-1 and PD-L1 Drug Market Size, 2018-2029
9.6.2 By Company, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.6.3 By Type, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.6.4 By Application, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan PD-1 and PD-L1 Drug Market Size, 2018-2029
9.7.2 By Company, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.7.3 By Type, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea PD-1 and PD-L1 Drug Market Size, 2018-2029
9.8.2 By Company, South Korea PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.8.3 By Type, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2018-2029
9.9.2 By Company, Southeast Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India PD-1 and PD-L1 Drug Market Size, 2018-2029
9.10.2 By Company, India PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.10.3 By Type, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.10.4 By Application, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia PD-1 and PD-L1 Drug Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
10.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application
10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bristol Myers Squibb Company Profile and Main Business
10.1.5 Bristol Myers Squibb Recent Developments
10.2 Merck & Co., Inc.
10.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
10.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application
10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Merck & Co., Inc. Company Profile and Main Business
10.2.5 Merck & Co., Inc. Recent Developments
10.3 F. Hoffmann -La Roche Ltd
10.3.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business
10.3.5 F. Hoffmann -La Roche Ltd Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application
10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Sanofi
10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.5.2 Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application
10.5.3 Sanofi PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Sanofi Company Profile and Main Business
10.5.5 Sanofi Recent Developments
10.6 Pfizer Inc
10.6.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position
10.6.2 Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application
10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Pfizer Inc Company Profile and Main Business
10.6.5 Pfizer Inc Recent Developments
10.7 Lilly
10.7.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.7.2 Lilly PD-1 and PD-L1 Drug Models, Specifications and Application
10.7.3 Lilly PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Lilly Company Profile and Main Business
10.7.5 Lilly Recent Developments
10.8 Novartis AG
10.8.1 Novartis AG Company Information, Head Office, Market Area and Industry Position
10.8.2 Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application
10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Novartis AG Company Profile and Main Business
10.8.5 Novartis AG Recent Developments
10.9 GSK
10.9.1 GSK Company Information, Head Office, Market Area and Industry Position
10.9.2 GSK PD-1 and PD-L1 Drug Models, Specifications and Application
10.9.3 GSK PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 GSK Company Profile and Main Business
10.9.5 GSK Recent Developments
10.10 Junshi Biosciences
10.10.1 Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
10.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application
10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Junshi Biosciences Company Profile and Main Business
10.10.5 Junshi Biosciences Recent Developments
10.11 Akeso, Inc
10.11.1 Akeso, Inc Company Information, Head Office, Market Area and Industry Position
10.11.2 Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application
10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Akeso, Inc Company Profile and Main Business
10.11.5 Akeso, Inc Recent Developments
10.12 BeiGene
10.12.1 BeiGene Company Information, Head Office, Market Area and Industry Position
10.12.2 BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application
10.12.3 BeiGene PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 BeiGene Company Profile and Main Business
10.12.5 BeiGene Recent Developments
10.13 Innovent
10.13.1 Innovent Company Information, Head Office, Market Area and Industry Position
10.13.2 Innovent PD-1 and PD-L1 Drug Models, Specifications and Application
10.13.3 Innovent PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Innovent Company Profile and Main Business
10.13.5 Innovent Recent Developments
10.14 Jiangsu Hengrui Medicine Co.,Ltd
10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position
10.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
10.15 Cstone
10.15.1 Cstone Company Information, Head Office, Market Area and Industry Position
10.15.2 Cstone PD-1 and PD-L1 Drug Models, Specifications and Application
10.15.3 Cstone PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Cstone Company Profile and Main Business
10.15.5 Cstone Recent Developments
10.16 Henlius
10.16.1 Henlius Company Information, Head Office, Market Area and Industry Position
10.16.2 Henlius PD-1 and PD-L1 Drug Models, Specifications and Application
10.16.3 Henlius PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Henlius Company Profile and Main Business
10.16.5 Henlius Recent Developments
10.17 Simcere Pharmaceutical Group Limited
10.17.1 Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position
10.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application
10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.17.4 Simcere Pharmaceutical Group Limited Company Profile and Main Business
10.17.5 Simcere Pharmaceutical Group Limited Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. PD-1 and PD-L1 Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. PD-1 and PD-L1 Drug Market Restraints
Table 3. PD-1 and PD-L1 Drug Market Trends
Table 4. PD-1 and PD-L1 Drug Industry Policy
Table 5. Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million
Table 6. Global PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023
Table 7. Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023
Table 9. Global PD-1 and PD-L1 Drug Price by Company, 2018-2023, (US$/Unit)
Table 10. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global PD-1 and PD-L1 Drug Manufacturers Product Type
Table 13. China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million
Table 14. China PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023
Table 15. China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)
Table 16. China PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, PD-1 and PD-L1 Drug Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China PD-1 and PD-L1 Drug Import & Export Trends
Table 19. Main Sources of China PD-1 and PD-L1 Drug Import
Table 20. Export Destination of China PD-1 and PD-L1 Drug
Table 21. Global Headquarters and Manufacturing Base of PD-1 and PD-L1 Drug Manufacturers
Table 22. Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans
Table 23. Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global PD-1 and PD-L1 Drug Production by Region, 2018-2023, (K Units)
Table 25. Global PD-1 and PD-L1 Drug Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)
Table 27. Global PD-1 and PD-L1 Drug Typical Customers
Table 28. PD-1 and PD-L1 Drug Typical Distributors
Table 29. By Type, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Table 33. By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global PD-1 and PD-L1 Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Table 36. By Country, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Table 37. By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Table 39. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position
Table 40. Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application
Table 41. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Bristol Myers Squibb Company Profile and Main Business
Table 43. Bristol Myers Squibb Recent Developments
Table 44. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position
Table 45. Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application
Table 46. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Merck & Co., Inc. Company Profile and Main Business
Table 48. Merck & Co., Inc. Recent Developments
Table 49. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
Table 51. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. F. Hoffmann -La Roche Ltd Company Profile and Main Business
Table 53. F. Hoffmann -La Roche Ltd Recent Developments
Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 55. AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application
Table 56. AstraZeneca PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AstraZeneca Company Profile and Main Business
Table 58. AstraZeneca Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 60. Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application
Table 61. Sanofi PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Pfizer Inc Company Information, Head Office, Market Area and Industry Position
Table 65. Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application
Table 66. Pfizer Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Pfizer Inc Company Profile and Main Business
Table 68. Pfizer Inc Recent Developments
Table 69. Lilly Company Information, Head Office, Market Area and Industry Position
Table 70. Lilly PD-1 and PD-L1 Drug Models, Specifications and Application
Table 71. Lilly PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Lilly Company Profile and Main Business
Table 73. Lilly Recent Developments
Table 74. Novartis AG Company Information, Head Office, Market Area and Industry Position
Table 75. Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application
Table 76. Novartis AG PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Novartis AG Company Profile and Main Business
Table 78. Novartis AG Recent Developments
Table 79. GSK Company Information, Head Office, Market Area and Industry Position
Table 80. GSK PD-1 and PD-L1 Drug Models, Specifications and Application
Table 81. GSK PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. GSK Company Profile and Main Business
Table 83. GSK Recent Developments
Table 84. Junshi Biosciences Company Information, Head Office, Market Area and Industry Position
Table 85. Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application
Table 86. Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Junshi Biosciences Company Profile and Main Business
Table 88. Junshi Biosciences Recent Developments
Table 89. Akeso, Inc Company Information, Head Office, Market Area and Industry Position
Table 90. Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application
Table 91. Akeso, Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Akeso, Inc Company Profile and Main Business
Table 93. Akeso, Inc Recent Developments
Table 94. BeiGene Company Information, Head Office, Market Area and Industry Position
Table 95. BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application
Table 96. BeiGene PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. BeiGene Company Profile and Main Business
Table 98. BeiGene Recent Developments
Table 99. Innovent Company Information, Head Office, Market Area and Industry Position
Table 100. Innovent PD-1 and PD-L1 Drug Models, Specifications and Application
Table 101. Innovent PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Innovent Company Profile and Main Business
Table 103. Innovent Recent Developments
Table 104. Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position
Table 105. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application
Table 106. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business
Table 108. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments
Table 109. Cstone Company Information, Head Office, Market Area and Industry Position
Table 110. Cstone PD-1 and PD-L1 Drug Models, Specifications and Application
Table 111. Cstone PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Cstone Company Profile and Main Business
Table 113. Cstone Recent Developments
Table 114. Henlius Company Information, Head Office, Market Area and Industry Position
Table 115. Henlius PD-1 and PD-L1 Drug Models, Specifications and Application
Table 116. Henlius PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 117. Henlius Company Profile and Main Business
Table 118. Henlius Recent Developments
Table 119. Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position
Table 120. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application
Table 121. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 122. Simcere Pharmaceutical Group Limited Company Profile and Main Business
Table 123. Simcere Pharmaceutical Group Limited Recent Developments
List of Figure
Figure 1. PD-1 and PD-L1 Drug Picture
Figure 2. By Revenue, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global PD-1 and PD-L1 Drug Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China PD-1 and PD-L1 Drug Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029
Figure 10. Global PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global PD-1 and PD-L1 Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China PD-1 and PD-L1 Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of PD-1 and PD-L1 Drug Domestic VS Export, 2022
Figure 16. Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global PD-1 and PD-L1 Drug Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029
Figure 19. PD-1 and PD-L1 Drug Industry Chain
Figure 20. PD-1 and PD-L1 Drug Procurement Model
Figure 21. PD-1 and PD-L1 Drug Sales Model
Figure 22. PD-1 and PD-L1 Drug Sales Channels, Direct Sales and Distribution
Figure 23. PD-1 Monoclonal Antibody
Figure 24. PD-L1 Monoclonal Antibody
Figure 25. By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Figure 26. By Type, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 27. By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 28. By Type, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 29. By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)
Figure 30. Liver Cancer
Figure 31. Esophageal Cancer
Figure 32. Nasal Cancer
Figure 33. Stomach Cancer
Figure 34. Other
Figure 35. By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million
Figure 36. By Application, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 37. By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 38. By Application, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 39. By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)
Figure 40. By Region, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029
Figure 41. By Region, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029
Figure 42. North America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, North America PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 44. Europe PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, Europe PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 46. Asia Pacific PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 48. South America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country, South America PD-1 and PD-L1 Drug Revenue Market Share, 2022
Figure 50. Middle East & Africa PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. U.S. PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 52. By Company, U.S. PD-1 and PD-L1 Drug Market Share, 2022
Figure 53. By Type, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 54. By Application, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 55. Europe PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 56. By Company, Europe PD-1 and PD-L1 Drug Market Share, 2022
Figure 57. By Type, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 58. By Application, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 59. China PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 60. By Company, China PD-1 and PD-L1 Drug Market Share, 2022
Figure 61. By Type, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 62. By Application, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 63. Japan PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 64. By Company, Japan PD-1 and PD-L1 Drug Market Share, 2022
Figure 65. By Type, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 66. By Application, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029
Figure 67. South Korea PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)
Figure 68. By Company,
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|